文献速递生殖医学

跨性别与性别多元人群的生育力:性别肯定激素对生殖器官及生育力影响的系统综述

Fertility in transgender and gender diverse people: systematic review of the effects of gender-affirming hormones on reproductive organs and fertility.
PubMed 文献 · Hum Reprod Update · 2025-01-01

本系统综述检索PubMed、Embase和Web of Science至2024年11月15日,纳入关于性别肯定激素治疗(GAHT)对性腺、配子、生育力及生育力保存影响的研究。使用睾酮者卵巢皮质与间质有组织学改变,多数研究提示卵泡生成持续活跃,但可能存在对受精率的负面影响;使用雌激素者睾丸萎缩、生精水平从完全生精到无精症不等,停用后可能恢复。作者建议反复评估生育意愿并探讨个体化生育力保存需求。

要点

  • 使用睾酮GAHT者卵巢皮质和间质有组织学改变,多数研究提示卵泡生成持续活跃。
  • 使用雌激素GAHT者睾丸萎缩、生精水平从完全生精到无精症不等,停用后可能恢复。
  • 作者建议在性别肯定治疗期间反复评估生育意愿并探讨个体化生育力保存需求。

核心结论

  • 关于GAHT对性腺和配子影响的知识不断增长,但仍存在盲点,需要在这一特定人群中开展更多研究。
  • 作者建议反复评估和重新评估生育意愿与偏好,并在性别肯定治疗期间探讨个体化生育力保存需求。
  • 作者指出,关于使用GAHT暴露后保存的配子所出生儿童的长期健康结局和生活质量,需要前瞻性随访研究。

研究设计与样本

  • 系统综述,已在PROSPERO注册,注册号为CRD42024516133。
  • 由医学信息专家检索PubMed、Embase和Web of Science,检索截至2024年11月15日。

主要发现

  • 使用睾酮GAHT者,多项研究报告卵巢皮质和间质改变。
  • 多数研究根据卵泡计数、分布和卵母细胞获取产量的描述,可得出卵泡生成持续活跃的结论。
  • 使用睾酮者可能存在对受精率的负面影响。
  • 使用雌激素GAHT后,睾丸萎缩更明显,包括生精小管变小伴重度透明变性和纤维化。
  • 使用雌激素和抗雄激素治疗导致精子异常比例更高(即总精子计数低、精子浓度低、精子活力差)或无精症,但停用后可能恢复。

临床怎么用

  • 作者建议反复评估和重新评估生育意愿与偏好。
  • 作者建议在性别肯定治疗期间探讨个体化生育力保存需求。

局限性

  • 作者指出,关于GAHT影响的知识仍存在盲点有待揭示。
  • 作者指出,需要在这一特定人群中开展更多研究,最好比较GAHT开始前后的结局。
  • 作者指出,研究建议还包括调查GAHT效果的可逆性,尤其是对年轻时开始过渡者。
  • 作者指出,关于使用GAHT暴露后保存的配子所出生儿童的长期健康结局和生活质量,需要前瞻性随访研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transgender and gender diverse (TGD) people seek gender-affirming care at any age to manage gender identities or expressions that differ from their birth gender. Gender-affirming hormone treatment (GAHT) and gender-affirming surgery may alter reproductive function and/or anatomy, limiting future reproductive options to varying degrees, if individuals desire to either give birth or become a biological parent. OBJECTIVE AND RATIONALE: TGD people increasingly pursue help for their reproductive questions, including fertility, fertility preservation, active desire for children, and future options. Their specific needs certainly require more insight into the effects of GAHT on gonads, gametes, and fertility. This systematic review aims to provide an overview of the current knowledge on the impact of GAHT on gonads, gametes, fertility, fertility preservation techniques, and outcomes. SEARCH METHODS: This review was registered in the PROSPERO registry under number CRD42024516133. A literature search (in PubMed, Embase, and Web of Science) was performed with a medical information specialist until 15 November 2024. OUTCOMES: In all TGD people using GAHT, histological changes have been reported.Using testosterone GAHT, ovarian cortical and stromal changes were reported by various studies. In most studies, persistent activity in folliculogenesis can be concluded based on the descriptions of the follicle count, distribution, and oocyte retrieval yield. However, there may be a negative effect on the fertilization rate in the presence of testosterone. Reports of successful ovarian stimulation, fertilization, pregnancies, and live births have been published, describing cases with and without testosterone discontinuation.After using oestrogen GAHT, testes are reported to be more atrophic, including smaller seminiferous tubules with heavy hyalinization and fibrosis. Spermatogenic levels varied widely from complete spermatogenesis to meiotic arrest with spermatids, to spermatogonial arrest, Sertoli cells only, or even tubular shadows. Oestrogen and anti-androgen treatment causes higher proportions of sperm abnormalities (i.e. low total sperm count, low sperm concentration, poor sperm motility) or azoospermia. However, after cessation, this may be restored. WIDER IMPLICATIONS: Although knowledge of the effect of GAHT is growing, blind spots remain to be uncovered. Therefore, additional research in this specific population is needed, preferably comparing outcomes before and after the start of GAHT. This may help to reveal the pure impact of GAHT on reproductive functioning. Research suggestions also include investigations into the reversibility of the GAHT effect, especially for those who start transition at a young age. Looking carefully at the presented data on GAHT effects on gonads and gametes, the correct advice is to assess and reassess reproductive wishes and preferences repeatedly, and also to explore individual fertility preservation needs during gender-affirming treatment, given the expanding knowledge and therapy opportunities. Finally, concerns regarding long-term health outcomes and quality of life of children born by the use of gametes preserved after exposure to GAHT require prospective follow-up studies.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. De Roo C, Schneider F, Stolk THR, et al. Fertility in transgender and gender diverse people: systematic review of the effects of gender-affirming hormones on reproductive organs and fertility. Hum Reprod Update. 2025. PMID: 39854640. doi:10.1093/humupd/dmae036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。